---
title: "Capsugel Healthcare Ltd (506887) — Share Price, Financials & Analysis"
symbol: "506887"
company: "Capsugel Healthcare Ltd"
canonical: "https://tapetide.com/stocks/506887"
isin: "INE565C01010"
bse_code: "506887"
generated_at: "2026-10-13T11:01:21.628Z"
---

# Capsugel Healthcare Ltd (506887)

Canonical page: https://tapetide.com/stocks/506887

## Company

- **BSE Code:** 506887
- **ISIN:** INE565C01010
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bharticapsules.com

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -41% |
| revenue growth | -8% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- | --- |
| Sales | 25.14 | 15.23 | 22.19 | 22.44 | 28.06 |
| Expenses | 23.29 | 14.57 | 20.9 | 16.84 | 24.67 |
| Operating Profit | 1.85 | 0.66 | 1.29 | 5.6 | 3.39 |
| OPM % | 7.36 | 4.33 | 5.81 | 24.96 | 12.08 |
| Other Income | 0.04 | 0.92 | 0.11 | 0.33 | 0.56 |
| Interest | 0.18 | 0.17 | 0.06 | 0.22 | 0.16 |
| Depreciation | 0.15 | 0.2 | 0.8 | 0.37 | 0.72 |
| Profit before tax | 1.56 | 1.21 | 0.54 | 5.34 | 3.07 |
| Tax % | 40.38 | 28.1 | 25.93 | 31.84 | 34.85 |
| Net Profit | 0.93 | 0.87 | 0.4 | 3.65 | 2.01 |
| EPS in Rs | 930 | 1.74 | 0.59 | 5.37 | 2.96 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 28 | 20 | 12 | 18 | 22 | 93 | 85 |
| Expenses | 26 | 28 | 36 | 38 | 34 | 93 | 92 |
| Operating Profit | 2 | -7 | -24 | -20 | -11 | 0 | -7 |
| OPM % | 8 | -37 | -209 | -109 | -51 | 0 | -8 |
| Other Income | -2 | 1 | 1 | 1 | 4 | 0 | 1 |
| Interest | 2 | 2 | 2 | 0 | 2 | 0 | 1 |
| Depreciation | 2 | 3 | 2 | 3 | 5 | 13 | 12 |
| Profit before tax | -3 | -12 | -28 | -22 | -14 | -13 | -19 |
| Tax % | 121 | -49 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | -8 | -6 | -28 | -23 | -14 | -13 | -19 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 9 | 9 | 89 | 101 | 101 | 218 | 218 |
| Reserves | -1 | -7 | -36 | -58 | -72 | -128 | -107 |
| Borrowings | 22 | 49 | 3 | 13 | 44 | 9 | 10 |
| Other Liabilities | 14 | 9 | 15 | 36 | 34 | 87 | 89 |
| Total Liabilities | 44 | 61 | 71 | 92 | 108 | 186 | 210 |
| Fixed Assets | 28 | 26 | 41 | 56 | 73 | 102 | 87 |
| CWIP | 4 | 25 | 16 | 15 | 3 | 0 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 9 | 15 | 21 | 32 | 84 | 118 |
| Total Assets | 44 | 61 | 71 | 92 | 108 | 186 | 210 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | -6 | -17 | 1 | -18 | — | — |
| Cash from Investing Activity | -5 | -20 | -11 | -22 | -10 | — | — |
| Cash from Financing Activity | 2 | 25 | 30 | 23 | 29 | — | — |
| Net Cash Flow | 0 | 0 | 2 | 1 | 1 | — | — |
| Free Cash Flow | -3 | -25 | -36 | -21 | -28 | — | — |
| CFO/OP | 126 | 75 | 70 | -6 | 157 | — | — |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 69 | 52 | 64 | 81 | 97 | 114 | 107 |
| Inventory Days | 272 | 186 | 294 | 237 | 436 | 278 | 211 |
| Days Payable | 358 | 384 | 984 | 2090 | 1288 | 209 | 177 |
| Cash Conversion Cycle | -17 | -146 | -626 | -1773 | -756 | 183 | 140 |
| Working Capital Days | 54 | -2 | -78 | -358 | -106 | -65 | -144 |
| ROCE % | — | -23 | -48 | -39 | -18 | — | -16 |

## Shareholding Pattern

### annual

| Category | Mar 2025 | Feb 2026 |
| --- | --- | --- |
| Promoters | 73.53% | 74.96% |
| FIIs | 0.16% | 0.02% |
| Public | 26.32% | 25.02% |
| No. of Shareholders | 662 | 509 |

### Quarterly

| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Feb 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 74.96% |
| FIIs | 0.09% | 0.22% | 0.22% | 0.16% | 0.16% | 0.16% | 0.03% | 0.02% |
| DIIs | 0.34% | 0.07% | 0.06% | 0% | 0.04% | 0% | 0% | 0% |
| Public | 26.04% | 26.17% | 26.18% | 26.32% | 26.27% | 26.3% | 26.45% | 25.02% |
| No. of Shareholders | 834 | 696 | 704 | 662 | 574 | 501 | 498 | 509 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 40.32 | Sell |
| EMA (10) | 40.22 | Sell |
| SMA (20) | 42.07 | Sell |
| EMA (20) | 41.49 | Sell |
| SMA (50) | 44.46 | Sell |
| EMA (50) | 44.25 | Sell |
| SMA (100) | 48.57 | Sell |
| EMA (100) | 47.9 | Sell |
| SMA (200) | 55.6 | Sell |
| EMA (200) | 54.09 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.56 | Neutral |
| MACD (12,26,9) | -1.6 | Sell |
| Stochastic (14,3,3) | 19.81 | Buy |
| ADX (14) | 12.95 | Neutral |
| Williams %R (14) | -76.66 | Neutral |
| ATR (14) | 1.57 | High Volatility |
| ROC (12) | -8.37 | Sell |
| Stoch RSI (14) | 61.79 | Neutral |
| UO (7,14,28) | 39.22 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-06 | [Intimation Of Receipt Of Listing Approval From Stock Exchanges Pursuant To Regulation 30 Of The SEBI (LODR), Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachLive/c7b6fe0a-03fe-4f33-8ea1-ae6eac2cb10b.pdf) |
| 2026-03-06 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1d538eb6-bbe7-4770-aab7-ffdad29a7c86.pdf) |
| 2026-03-06 | [Business Update](https://www.bseindia.com/xml-data/corpfiling/AttachLive/37c598f7-97b4-4cc7-83ab-d946ea4c6dd5.pdf) |
| 2026-03-05 | [Business Update](https://www.bseindia.com/xml-data/corpfiling/AttachLive/21dab77c-cd6a-494b-bc7b-3d474bb95bf6.pdf) |
| 2026-02-25 | [Business Update](https://www.bseindia.com/xml-data/corpfiling/AttachHis/41b06617-b94c-47fd-82a9-d61feafcd62c.pdf) |
| 2026-02-16 | [Business Update](https://www.bseindia.com/xml-data/corpfiling/AttachHis/60713bb0-68fd-471b-9160-ad1e614c8ba0.pdf) |
| 2026-02-10 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca6b546e-2ae2-4a94-bbab-2766ec535749.pdf) |
| 2026-02-10 | [Revised Outcome Of Board Meeting Held On 10Th February, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8bfa9a5-2b44-4fcd-a4dd-d80e2099fcd8.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2601fce2-6028-4220-88c1-f0ff30aacf25.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5fd2fb0-5b69-46a3-9d68-c963ff34552f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d7c9c21-46d1-4483-ac3b-902144822870.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30b2b38e-944b-4b1f-b335-958865b84762.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cebe6c98-c5e4-4d53-b5a4-cb2c832b043d.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:21.628Z.